Hazards, by-products, and squander products that are not as consequential at more compact scale can become key issues at huge scale, thus, it is vital to factor these criteria in from the beginning.="" in="" accordance="" with="" the="" regulatory="" flexibility="" act,="" fda="" has="" viewed as="" the="" outcome="" of="" this="" motion="" on="" t